Vertex Changes Timing of Third Quarter 2013 Earnings Call On October 29

  Vertex Changes Timing of Third Quarter 2013 Earnings Call On October 29

Business Wire

CAMBRIDGE, Mass. -- October 10, 2013

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third
quarter 2013 financial results on Tuesday, October 29, 2013 before the
financial markets open. The company will host a conference call and webcast at
8:30 a.m. EDT. This is an update to the previous timing of postmarket results
with a 5:00 p.m. EDT conference call. All other call information is the same.
To access this call, dial (866) 501-1537 (U.S.) or +1 (720) 545-0001

The conference call will be webcast live and a link to the webcast may be
accessed from the “Vertex Events” page of Vertex’s website at A
replay of the conference call and webcast will be archived on the company’s
website until November 5, 2013. To ensure a timely connection, it is
recommended that users register at least 15 minutes prior to the scheduled

About Vertex

Vertex creates new possibilities in medicine. Our team discovers, develops and
commercializes innovative therapies so people with serious diseases can lead
better lives.

Vertex scientists and our collaborators are working on new medicines to cure
or significantly advance the treatment of hepatitis C, cystic fibrosis,
rheumatoid arthritis and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada. Today,
Vertex has more than 2,000 employees around the world, and for three years in
a row, Science magazine has named Vertex one of its Top Employers in the life
sciences. Vertex’s press releases are available at


Vertex (Investors):
Michael Partridge, 617-341-6108
Kelly Lewis, 617-961-7530
Vertex (Media):
Zach Barber, 617-341-6470
Press spacebar to pause and continue. Press esc to stop.